Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Human serum promotes Candida albicans biofilm growth and virulence gene expression on silicone biomaterial.

Samaranayake YH, Cheung BP, Yau JY, Yeung SK, Samaranayake LP.

PLoS One. 2013 May 21;8(5):e62902. doi: 10.1371/journal.pone.0062902. Print 2013.

2.

Enteric Gram-negative bacilli suppress Candida biofilms on Foley urinary catheters.

Samaranayake YH, Bandara HM, Cheung BP, Yau JY, Yeung SK, Samaranayake LP.

APMIS. 2014 Jan;122(1):47-58. doi: 10.1111/apm.12098. Epub 2013 May 8.

PMID:
23656511
3.

Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production.

Samaranayake YH, Cheung BP, Wang Y, Yau JY, Yeung KW, Samaranayake LP.

J Med Microbiol. 2013 Feb;62(Pt 2):303-18. doi: 10.1099/jmm.0.044123-0. Epub 2012 Sep 20.

PMID:
23002065
4.

Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.

Samaranayake YH, Cheung BP, Yau JY, Yeung KW, Samaranayake LP.

J Investig Clin Dent. 2011 May;2(2):117-27. doi: 10.1111/j.2041-1626.2011.00044.x. Epub 2011 Feb 18.

PMID:
25426605
5.

The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.

Samaranayake YH, Yau JY, Thein ZM, Jayatilake JA, Yeung KW, Samaranayake LP.

Med Mycol. 2010 Aug;48(5):725-34. doi: 10.3109/13693780903496583.

PMID:
20092419
6.

Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms.

Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2009 Nov;54(11):1052-60. doi: 10.1016/j.archoralbio.2009.08.002. Epub 2009 Aug 26.

PMID:
19712926
7.

Community lifestyle of Candida in mixed biofilms: a mini review.

Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP.

Mycoses. 2009 Nov;52(6):467-75. doi: 10.1111/j.1439-0507.2009.01719.x. Epub 2009 May 27. Review.

PMID:
19486299
8.

Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.

Samaranayake YH, Cheung BP, Parahitiyawa N, Seneviratne CJ, Yau JY, Yeung KW, Samaranayake LP.

Arch Oral Biol. 2009 Feb;54(2):115-26. doi: 10.1016/j.archoralbio.2008.09.015. Epub 2008 Nov 26.

PMID:
19038377
9.

Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.

Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP.

Antimicrob Agents Chemother. 2008 Sep;52(9):3259-66. doi: 10.1128/AAC.00541-08. Epub 2008 Jul 14.

10.

A comparative study of candidal invasion in rabbit tongue mucosal explants and reconstituted human oral epithelium.

Jayatilake JA, Samaranayake YH, Samaranayake LP.

Mycopathologia. 2008 Jun;165(6):373-80. doi: 10.1007/s11046-008-9096-1. Epub 2008 Mar 5.

PMID:
18320346
11.

Characteristics of dual species Candida biofilms on denture acrylic surfaces.

Thein ZM, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2007 Dec;52(12):1200-8. Epub 2007 Aug 6.

PMID:
17681271
12.

In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions.

Thein ZM, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2007 Aug;52(8):761-7. Epub 2007 Feb 23.

PMID:
17321487
13.

Differential phospholipase gene expression by Candida albicans in artificial media and cultured human oral epithelium.

Samaranayake YH, Dassanayake RS, Cheung BP, Jayatilake JA, Yeung KW, Yau JY, Samaranayake LP.

APMIS. 2006 Dec;114(12):857-66.

PMID:
17207086
14.
15.

DNA fingerprinting elicited evolutionary trend of oral Candida tropicalis isolates from diverse geographic locales.

Dassanayake RS, Samaranayake YH, Yau J, Samaranayake LP.

Indian J Med Microbiol. 2006 Jul;24(3):186-94.

16.

Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.

Parahitiyawa NB, Samaranayake YH, Samaranayake LP, Ye J, Tsang PW, Cheung BP, Yau JY, Yeung SK.

APMIS. 2006 Apr;114(4):298-306.

PMID:
16689830
17.

Effect of oral bacteria on growth and survival of Candida albicans biofilms.

Thein ZM, Samaranayake YH, Samaranayake LP.

Arch Oral Biol. 2006 Aug;51(8):672-80. Epub 2006 Apr 18.

PMID:
16620775
18.

Characterization of switch phenotypes in Candida albicans biofilms.

Jin Y, Samaranayake YH, Yip HK, Samaranayake LP.

Mycopathologia. 2005 Oct;160(3):191-200.

PMID:
16205967
19.

Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection.

Samaranayake YH, Dassanayake RS, Jayatilake JA, Cheung BP, Yau JY, Yeung KW, Samaranayake LP.

J Med Microbiol. 2005 Jun;54(Pt 6):583-93.

PMID:
15888468
20.

The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms.

Jin Y, Zhang T, Samaranayake YH, Fang HH, Yip HK, Samaranayake LP.

Mycopathologia. 2005 Apr;159(3):353-60.

PMID:
15883718
21.

An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium.

Jayatilake JA, Samaranayake YH, Samaranayake LP.

J Oral Pathol Med. 2005 Apr;34(4):240-6.

PMID:
15752260
22.

In vitro method to study antifungal perfusion in Candida biofilms.

Samaranayake YH, Ye J, Yau JY, Cheung BP, Samaranayake LP.

J Clin Microbiol. 2005 Feb;43(2):818-25.

23.

The effect of fixed orthodontic appliances on the oral carriage of Candida species and Enterobacteriaceae.

Hägg U, Kaveewatcharanont P, Samaranayake YH, Samaranayake LP.

Eur J Orthod. 2004 Dec;26(6):623-9.

PMID:
15650072
24.

Adhesion and cell-surface-hydrophobicity of sequentially isolated genetic isotypes of Candida albicans in an HIV-infected Southern Chinese cohort.

Samaranayake YH, Samaranayake LP, Yau JY, Ellepola AN, Anil S, Yeung KW.

Mycoses. 2003;46(9-10):375-83.

PMID:
14622385
25.
26.

Phenotypic diversity of oral C. albicans isolated on single and sequential visits in an HIV-infected Chinese cohort.

Samaranayake YH, Samaranayake LP, Yau JY, Dassanayake RS, Li TK, Anil S.

APMIS. 2003 Feb;111(2):329-37.

PMID:
12716390
27.

'Genotypic shuffling' of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis.

Samaranayake YH, Samaranayake LP, Dassanayake RS, Yau JY, Tsang WK, Cheung BP, Yeung KW.

J Med Microbiol. 2003 Apr;52(Pt 4):349-59.

PMID:
12676875
28.

High oral prevalence of Candida krusei in leprosy patients in northern Thailand.

Reichart PA, Samaranayake LP, Samaranayake YH, Grote M, Pow E, Cheung B.

J Clin Microbiol. 2002 Dec;40(12):4479-85.

29.

Molecular heterogeneity of fluconazole-resistant and -susceptible oral Candida albicans isolates within a single geographic locale.

Dassanayake RS, Ellepola AN, Samaranayake YH, Samaranayak LP.

APMIS. 2002 Apr;110(4):315-24.

PMID:
12076267
31.

Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.

Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.

J Oral Pathol Med. 2001 Jul;30(6):336-46.

PMID:
11459319
32.

Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method.

Samaranayake YH, Samaranayake LP, Yeung KW.

Chemotherapy. 2001 Jul-Aug;47(4):279-91.

PMID:
11399865
33.

Experimental oral candidiasis in animal models.

Samaranayake YH, Samaranayake LP.

Clin Microbiol Rev. 2001 Apr;14(2):398-429. Review.

34.

Genomic diversity of oral Candida krusei isolates as revealed by DNA fingerprinting and electrophoretic karyotyping.

Dassanayake RS, Samaranayake YH, Samaranayake LP.

APMIS. 2000 Oct;108(10):697-704.

PMID:
11200825
35.

In vitro susceptibility of Candida species to lactoferrin.

Xu YY, Samaranayake YH, Samaranayake LP, Nikawa H.

Med Mycol. 1999 Feb;37(1):35-41.

PMID:
10200932
36.

The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.

Samaranayake YH, Wu PC, Samaranayake LP, Ho PL.

J Med Microbiol. 1998 Dec;47(12):1047-57.

PMID:
9856640
37.

The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.

Samaranayake YH, Samaranayake LP, Wu PC, So M.

APMIS. 1997 Nov;105(11):875-83.

PMID:
9393559
38.
39.

Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

Samaranayake YH, Samaranayake LP.

J Med Microbiol. 1994 Nov;41(5):295-310. Review.

PMID:
7966200
40.

Adhesion and colonisation of Candida krusei on host surfaces.

Samaranayake YH, Wu PC, Samaranayake LP, So M, Yuen KY.

J Med Microbiol. 1994 Oct;41(4):250-8.

PMID:
7932617
41.

The in vitro proteolytic and saccharolytic activity of Candida species cultured in human saliva.

Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison T.

Oral Microbiol Immunol. 1994 Aug;9(4):229-35.

PMID:
7478763
42.

The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media.

Samaranayake YH, MacFarlane TW, Aitchison TC, Samaranayake LP.

Oral Microbiol Immunol. 1993 Jun;8(3):177-81.

PMID:
8233572
43.

The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media.

Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison TC.

Microbios. 1993;74(298):23-8.

PMID:
8336552

Supplemental Content

Loading ...
Support Center